431 related articles for article (PubMed ID: 17302011)
1. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
Demchak C
Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
[No Abstract] [Full Text] [Related]
2. Chronic conditions and disabilities: trends and issues for private drug plans.
Boccuti C; Moon M; Dowling K
Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
[No Abstract] [Full Text] [Related]
3. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
Briesacher B; Stuart B; Shea D
Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
[No Abstract] [Full Text] [Related]
4. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty.
Shea DG; Stuart BC; Briesacher B
Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411
[No Abstract] [Full Text] [Related]
5. Medicare: looking for pareto optimal changes.
Christensen S
Inquiry; 1992; 29(4):426-39. PubMed ID: 1473866
[TBL] [Abstract][Full Text] [Related]
6. Medicare Part D subsidies. Final rules.
Social Security Administration (SSA)
Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
[TBL] [Abstract][Full Text] [Related]
7. Medigap: prevalence, premiums, and opportunities for reform.
Super N
NHPF Issue Brief; 2002 Sep; (782):1-23. PubMed ID: 12240698
[TBL] [Abstract][Full Text] [Related]
8. Private, individual drug coverage in the current Medicare market.
Boccuti C; Moon M
Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
[No Abstract] [Full Text] [Related]
9. Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002.
Gold M; Achman L
Issue Brief (Commonw Fund); 2002 Nov; (575):1-8. PubMed ID: 12425302
[No Abstract] [Full Text] [Related]
10. Access to Medicare Part D gap coverage more scarce in 2007.
Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
[No Abstract] [Full Text] [Related]
11. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
Cubanski J; Neuman P
Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
[TBL] [Abstract][Full Text] [Related]
12. Coordination of benefits.
Anderson LS
Issue Brief Cent Medicare Educ; 2003; 4(10):1-6. PubMed ID: 14992217
[TBL] [Abstract][Full Text] [Related]
13. Dramatic improvement or death spiral--two members of congress assess the Medicare bill.
Kennedy EM; Thomas B
N Engl J Med; 2004 Feb; 350(8):747-51. PubMed ID: 14973220
[No Abstract] [Full Text] [Related]
14. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
[No Abstract] [Full Text] [Related]
15. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
Austin BJ
Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
[TBL] [Abstract][Full Text] [Related]
16. Are women better off because of the new Medicare drug legislation?
Moon M
Womens Health Issues; 2005; 15(1):1-4. PubMed ID: 15661581
[TBL] [Abstract][Full Text] [Related]
17. How beneficiaries fare under the new Medicare drug bill.
Moon M
Issue Brief (Commonw Fund); 2004 Jun; (730):1-16. PubMed ID: 15176395
[TBL] [Abstract][Full Text] [Related]
18. The new Medicare prescription-drug legislation.
Altman DE
N Engl J Med; 2004 Jan; 350(1):9-10. PubMed ID: 14702422
[No Abstract] [Full Text] [Related]
19. Highlights of the Medicare Prescription Drug Act.
Conomikes GS
J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
[No Abstract] [Full Text] [Related]
20. Should you switch Medicare plans?
Consum Rep; 2004 Sep; 69(9):51. PubMed ID: 15305428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
